Novartis has reported new data with its multiple sclerosis (MS) drug ofatumumab showing that it can suppress disease activity for up to two years, as it waits for an FDA decision on the drug next ...

If I were to flip you the bird left-handed, which I sometimes do to mix things up, you’d notice that my middle finger is crooked, with a bulged knuckle. Why does it look like that? Catfish noodling.